Stay informed with the latest updates for the inheritable blood disorders community. Industry GenVec and WU Enter Hemophilia Therapies AgreementJan 12, 2017 Industry FDA will Review LFB's Application for Recombinant Factor VIIa TherapyJan 11, 2017 Industry Sangamo Receives FDA Approval for Hemophilia A Gene Therapy TrialJan 10, 2017 Industry BioMarin’s Hemophilia A Gene Therapy Trial Demonstrates Increased FVIII…Jan 9, 2017 Medical Nurses' Guide Updates Travel Planning ChapterJan 6, 2017 Industry Updated: Genentech's Subcutaneous Therapy Performing Well in StudyJan 3, 2017 NBDF & Community Calling All Men Age 50+ Living with HemophiliaDec 27, 2016 Industry Octapharma Reports Data on Inhibitor Rates in Nuwiq® Trial Dec 22, 2016 Medical New Medscape Activity on Adolescents and SportsDec 21, 2016 Industry UniQure’s Hemophilia B Gene Therapy Performs Well in Clinical TrialDec 19, 2016 Advocacy & Legislative CMS Cancels Controversial Medicare Part B DemoDec 16, 2016 Industry CSL Behring Presents Data on Therapeutic Potential of Idelvion® Dec 15, 2016 NBDF & Community …Dec 15, 2016 Industry Biogen Reports ELOCTATE™ Shows Positive Implications for Quality of LifeDec 14, 2016 Industry Alnylam Reports Progress on Investigational Subcutaneous Hemophilia…Dec 13, 2016 Pagination First page Previous page … Page 58 Page 59 Page 60 Page 61 Current page 62 Page 63 Page 64 Page 65 Page 66 … Next page Last page
